Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Andrew Elliott Place, M.D., Ph.D.

Concepts (242)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Andrew Place's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Andrew Place has written about over time.
Oleanolic Acid, 6 publications between 1999 and 2005, average publication date April 2002. Antineoplastic Agents, 8 publications between 1999 and 2018, average publication date January 2011. Escherichia coli Proteins, 1 publications between 2015 and 2015, average publication date November 2015. Hematologic Neoplasms, 2 publications between 2013 and 2018, average publication date April 2016. Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, 3 publications between 2016 and 2018, average publication date August 2017. Clinical Protocols, 1 publications between 2018 and 2018, average publication date March 2018. Sulfonamides, 1 publications between 2018 and 2018, average publication date March 2018. Polyethylene Glycols, 3 publications between 2015 and 2021, average publication date July 2018. Bacillus, 1 publications between 2018 and 2018, average publication date December 2018. Bacteremia, 1 publications between 2018 and 2018, average publication date December 2018. Neutropenia, 1 publications between 2018 and 2018, average publication date December 2018. Antineoplastic Combined Chemotherapy Protocols, 8 publications between 2018 and 2024, average publication date February 2021. Asparaginase, 7 publications between 2015 and 2024, average publication date February 2021. Precursor Cell Lymphoblastic Leukemia-Lymphoma, 13 publications between 2015 and 2024, average publication date May 2021. Cataract, 1 publications between 2022 and 2022, average publication date January 2022. Thrombocytopenia, 1 publications between 2022 and 2022, average publication date January 2022. Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, 4 publications between 2020 and 2023, average publication date April 2022.

To see the data from this visualization as text, click here.
Place's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (242)
Explore
_
Co-Authors (91)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.